PBD Biotech has developed the only rapid, sensitive test to detect live mycobacteria, which are responsible for bovine TB and Johne’s Disease, both economically disastrous.
The company was recently awarded the Royal Dairy Innovation Award and now has been short-listed as a leading biotech company by Business Weekly.
Trials have demonstrated the effectiveness of the test Actiphage, which can detect mycobacteria at low levels in blood or milk within six hours. The test has applications in quality control of dairy products, and could revolutionise the way bovine TB and other livestock diseases are identified and managed.
The company was established in 2016 and has gained funding, UK government approval, proven efficacy in the field, opened an office in Canada and started international trials.